http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
USO Names 2025 USO Volunteers of the Year
-
Upper Deck Introduces NHL Rookie Debut Jersey Cards 30 Years After Pioneering First-Ever Game-Used Jersey Trading Cards
-
Florida State Board of Education Approves Carnegie Learning’s ¡Qué chévere! and T’es branché? Curriculum
-
Vystar submits letter to acquire stake in GoPaid and launch collectibles platform
-
Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles
-
SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies
-
SU2C DREAM TEAM TARGETS EARLY DETECTION OF GASTRIC CANCER
-
Alectra’s community giving recognized with Imagine Canada PRISM Certification
-
Freddie Mac Multifamily Issued $68 Billion in 2025 Securities
-
Ardelyx reports $378 million in 2025 revenue, projects growth
-
Operation HOPE Names Van Jones as Co-Chair of HOPE AI™
-
Konica Minolta Recognized as a Leader in 2025-26 IDC MarketScape for Worldwide Print Security Solutions and Services Hardcopy
-
iHeartMedia and FOX Entertainment Announce Nominees for the 2026 iHeartRadio Music Awards
-
Provation Launches Mira iPro Insights: Unlocking Instant Intelligence from the Industry’s Most Comprehensive Perioperative Data Platform
-
ThreatModeler Acquires IriusRisk to Build Seamless Security For Enterprises In the AI Coding Era
-
Chobani's Legacy Project Fund Expands to Four States
-
Edmunds Honored in Built In’s Distinguished 2026 Best Places to Work Awards
-
Discover the 10 Top Meme Coin Opportunities for Your Portfolio – APEMARS Presale Awaits
-
AISIX Solutions Inc. to Speak on Sharper Models for Sharper Risks Panel at CatIQ 2026
-
Equable Institute Analysis: U.S. Public Pension Funds Close 2025 with Strong Returns
-
Biofrontera locks databases for actinic keratosis and acne studies
-
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones
-
Leslie's appoints John Hartmann as independent board director
-
Hughes Network Systems Receives Frost & Sullivan's 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity
-
Leslie’s, Inc. Appoints John Hartmann to Board of Directors
-
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
-
BJ's Restaurant & Brewhouse Brings the Crispety, Crunchety and Peanut-Buttery Goodness of Butterfinger® to the World-Famous Pizookie® Dessert
-
Josh Weinstein, President & CEO of Carnival Corporation & plc, named Chair of the Global Executive Committee of Cruise Lines International Association
-
MDA SPACE receives contract from U.S. Missile Defense Agency
-
MDA SPACE SELECTED BY MISSILE DEFENSE AGENCY FOR SHIELD PROGRAM
-
CORRECTING and REPLACING – BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
-
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
-
Walmart names Shishir Mehrotra to board of directors
-
Emergent BioSolutions provides funding for mpox treatment study in Africa
-
Tvardi shares additional Phase 2 data showing fibrosis improvement
-
Halozyme partners with Takeda for vedolizumab drug delivery technology
-
Walmart names Shishir Mehrotra to Board of Directors
-
Toshiba Unveils Next-Generation Retail Solutions at NRF 2026, Reinforcing Its Commitment to Retailers' Evolving Needs
-
Strategic Resources Expands its Board of Directors and Management Team
-
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Suki Expands Executive Leadership With the Addition of Abhi Pathak as Chief Product Officer
-
PKF O'Connor Davies Announces Key Leadership Appointments to Drive Strategic Growth
-
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
-
CytomX Therapeutics Announces Business Update and Company Milestones for 2026
-
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
-
Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE®
-
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
-
Auxly Reviews 2025 Milestones and Provides 2026 Outlook
-
Trailbreaker Expands Footprint of High-Grade Gold Structure at Atsutla Gold Project, BC
-
Soluna partners with Siemens on 2 MW pilot to manage AI power demands
